AstraZeneca Pharma India yesterday reported a 45.03 per cent decline in its net profit to Rs 10.24 crores for the June-ended quarter. The company had posted a net profit of Rs 18.63 crores for the corresponding period of the previous fiscal, AstraZeneca Pharma India said in a regulatory filing.
Revenue from operations stood at Rs 175.40 crores for the quarter under consideration. It was Rs 193.57 crores for the same period a year ago, it added.
The company’s board of directors has declared an interim dividend of Rs 2 per equity share for the financial year 2021-22, the filing said.